|
Difference in sensitivity pattern of frequently isolated Gram negative rods during two halves of study period. |
||||||||||
| (a) |
||||||||||
|
|
||||||||||
| Enterobacteriaceae |
Pseudomonas. aeruginosa |
|||||||||
|
|
|
|||||||||
| Period 1 |
Period II |
Period I |
Period II |
|||||||
|
|
|
|
|
|||||||
| n = 55 |
% |
n = 212 |
% |
P-value |
n = 15 |
% |
n = 34 |
% |
P-value |
|
|
|
||||||||||
| Amikacin |
6 |
10.9 |
35 |
16.5 |
0.305 |
0 |
0 |
4 |
11.8 |
0.298 # |
| Amox/clav |
25 |
45.5 |
102 |
48.1 |
0.725 |
NT |
NT |
NT |
NT |
- |
| Ceftriaxone |
13 |
23.6 |
118 |
55.7 |
< 0001* |
NT |
NT |
NT |
NT |
- |
| Ciprofloxacin |
15 |
27.3 |
105 |
49.5 |
0.003 * |
2 |
13.3 |
10 |
29.4 |
0.298 # |
| Tazocin |
0 |
0 |
24 |
11.3 |
0.006 * |
0 |
0 |
4 |
11.8 |
0.298 # |
| Imipenem |
0 |
0 |
0 |
0 |
- |
0 |
0 |
2 |
5.9 |
0.999 # |
| Ceftazidime |
NT |
NT |
NT |
NT |
- |
1 |
6.7 |
2 |
5.9 |
0.999 # |
|
|
||||||||||
| (b) |
||||||||||
|
|
||||||||||
| Pseudomonas species |
Acinetobactor |
|||||||||
| Period 1 |
Period II |
Period 1 |
Period II |
|||||||
|
|
|
|
|
|||||||
| n = 8 |
% |
n = 29 |
% |
p-value |
n = 6 |
% |
n = 52 |
% |
p-value |
|
|
|
||||||||||
| Amikacin |
4 |
50.0 |
12 |
41.4 |
0.705 # |
1 |
16.7 |
27 |
51.9 |
0.195 # |
| Amox/clavilunate |
NT |
NT |
NT |
NT |
- |
NT |
NT |
NT |
NT |
- |
| Ceftriaxone |
0 |
0 |
7 |
24.1 |
0.308 # |
0 |
0 |
39 |
75.0 |
0.001 #* |
| Ciprofloxacin |
1 |
12.5 |
7 |
24.1 |
0.655 # |
0 |
0 |
33 |
63.5 |
0.004 #* |
| Pipracillin/Tazobactam |
0 |
0 |
2 |
6.9 |
0.999 # |
0 |
0 |
34 |
65.4 |
0.003 #* |
| Imipenem |
0 |
0 |
6 |
20.7 |
0.305 # |
0 |
0 |
34 |
65.4 |
0.003 #* |
| Ceftazidime |
NT |
NT |
NT |
NT |
- |
NT |
NT |
NT |
NT |
- |
|
p-values calculated by Chi square test otherwise indicated # p-value calculated by Fisher exact test * p < 0.05 | ||||||||||
Irfan et al. BMC Infectious Diseases 2008 8:80 doi:10.1186/1471-2334-8-80 |
||||||||||